Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902219-24-000388
Filing Date
2024-11-08
Accepted
2024-11-08 10:34:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 26372
2 JOINT FILING AGREEMENT Rule13D_JointFilingAgreement.htm EX-99 3761
  Complete submission text file 0000902219-24-000388.txt   32349
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address ONE EDWARDS WAY IRVINE CA 92614
Business Address ONE EDWARDS WAY IRVINE CA 92614 9492502500
Edwards Lifesciences Corp (Subject) CIK: 0001099800 (see all company filings)

EIN.: 364316614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60355 | Film No.: 241438517
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
(CF Office: 08 Industrial Applications and Services)